Preferred Label : Hand-Foot syndrome;

MeSH definition : Chemotherapy-induced dermal side effects that are associated with the use of various CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe ulcerative dermatitis with debilitating pain involving typically palmoplantar and intertriginous areas. These cutaneous manifestations are sometimes accompanied by nail anomalies.;

MeSH synonym : Hand-Foot syndromes; syndrome, Hand-Foot; syndromes, Hand-Foot; Chemotherapy-Induced palmoplantar erythrodysesthesia; chemotherapy induced palmoplantar erythrodysesthesia; Chemotherapy-Induced palmoplantar erythrodysesthesias; palmoplantar erythrodysesthesia, Chemotherapy-Induced; palmoplantar erythrodysesthesias, Chemotherapy-Induced; Chemotherapy-Induced acral erythema; acral erythema, Chemotherapy-Induced; acral erythemas, Chemotherapy-Induced; chemotherapy induced acral erythema; Chemotherapy-Induced acral erythemas; hand foot syndrome;

MeSH annotation : do not confuse with HAND, FOOT AND MOUTH DISEASE;

Wikipedia link supervised : https://en.wikipedia.org/wiki/Hand-foot syndrome;

Details


Main resources

You can consult :

Chemotherapy-induced dermal side effects that are associated with the use of various CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe ulcerative dermatitis with debilitating pain involving typically palmoplantar and intertriginous areas. These cutaneous manifestations are sometimes accompanied by nail anomalies.

http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=2438
2014
false
true
false
France
scientific and technical information
uterus
Hand-Foot syndrome

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/46/C8/resume.phtml?type=text.html
2009
false
France
French
journal article
phenylurea compounds
niacinamide
Tyrosine Kinase Inhibitors
benzenesulfonates
pyridines
Hand-Foot syndrome
antineoplastic agents
sorafenib
administration, oral
protein kinase inhibitors
sorafenib tosylate
receptors, vascular endothelial growth factor
kidney neoplasms
carcinoma, hepatocellular
receptors, platelet-derived growth factor
raf kinases
paresthesia
erythema
Sorafenib

---
Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.